I love the sheer volume of developments a simple google search brings up now for stem cells. 4 overnight developments on northern hemisphere time. It might have been 1 or 2 at best pre-COVID. The pace for developments has noticeably picked up and the FDA can no longer deny the noise....:
Even the Aussie government picking up on the advancements and possibilities ($150 million investment):
https://www.health.gov.au/our-work/mrff-stem-cell-therapies-mission
Capital investments getting announced near weekly now:
https://www.investing.com/news/stock-market-news/earnings-call-biolinerx-announces-fda-approval-of-stem-cell-mobilization-drug-motixafortide-93CH-3239578
"Additionally, BioLineRx has closed an exclusive license agreement with Gloria Biosciences for the development and commercialization of Motixafortide in Asia. This agreement includes an upfront payment of $15 million, with potential milestone and royalty payments totaling up to $250 million. This partnership is significant considering Asia reported over 51,000 cases of multiple myeloma in 2022, marking it as a substantial market."
(Motixafortide in autologous hematopoietic stem cell-based gene therapy for sickle cell disease)
banter and General Discussion, page-7870
-
- There are more pages in this discussion • 2,260 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |